Striking the right balance

被引:0
作者
不详
机构
关键词
D O I
10.1038/nrd2178
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The recent report from the Institute of Medicine on the US systems for ensuring drug safety emphasized deficiencies in post-approval assessment of drug risks. As the drug safety debate progresses, the importance of assessing drug risks and benefits together should not be forgotten, and nor should the harm that can be caused by undue delay of new therapies.
引用
收藏
页码:879 / 879
页数:1
相关论文
共 2 条
  • [1] POLLACK A, 2006, NY TIMES 0929
  • [2] 2006, FUTURE DRUG SAFETY P